April 28, 2020 / 6:07 AM / a month ago

BRIEF-Marinomed Biotech Gets FFG Funding To Research Sars-Cov-2 Therapy Based On Carragelose

April 28 (Reuters) - MARINOMED BIOTECH AG:

* MARINOMED RECEIVES FFG FUNDING TO RESEARCH SARS-COV-2 THERAPY BASED ON CARRAGELOSE

* AUSTRIAN RESEARCH PROMOTION AGENCY (FFG) FUNDS UP TO 45% OF PLANNED PROJECT VOLUME OF OVER EUR 4 MILLION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below